FDA needs to loosen up on CBD but clamp down on quality claims
May 22, 2019 at 08:33 AM EDT
Enhance consumer protections by establishing product quality-assurance standards, not by restricting access to CBD.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|